OSE Immunotherapeutics SAEURONEXT: OSE

Informations relatives au nombre total de droits de vote et d’actions composant le capital

· Issued by OSE Immunotherapeutics SA via Euronext

Filed with Euronext · · 1 page · French

Summary by 6ix AI

It includes details about newly issued shares as part of a financing arrangement with IRIS Capital Investment. The document also outlines the theoretical voting rights based on all shares, including those without voting rights.

Written in English by 6ix AI from the company’s French-language filing. How 6ix writes summaries

OSE Immunotherapeutics SA on 6ix

Earlier from OSE Immunotherapeutics

Later from OSE Immunotherapeutics

All OSE Immunotherapeutics news releases